Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW. Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener. 2021;16(1):83. https://doi.org/10.1186/s13024-021-00501-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goedert M, Jakes R, Spillantini MG. The synucleinopathies: twenty years on. J Parkinsons Dis. 2017;7(s1):S51–69. https://doi.org/10.3233/JPD-179005.

Article  PubMed  PubMed Central  Google Scholar 

McCann H, Stevens CH, Cartwright H, Halliday GM. alpha-Synucleinopathy phenotypes. Parkinsonism Relat Disord. 2014;20(Suppl 1):S62–7. https://doi.org/10.1016/S1353-8020(13)70017-8.

Article  PubMed  Google Scholar 

Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci. 2000;920:16–27. https://doi.org/10.1111/j.1749-6632.2000.tb06900.x.

Article  CAS  PubMed  Google Scholar 

Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/statistics. Accessed 5 Sept 2023.

Hess CW, Okun MS. Diagnosing Parkinson disease. Continuum Minneap Minn. 2016;22(4):1047–63. https://doi.org/10.1212/CON.0000000000000345.

Article  PubMed  Google Scholar 

World Health Organization. Parkinson disease. https://www.who.int/news-room/fact-sheets/detail/parkinson-disease. Accessed 5 Sept 2023.

Astrom DO, et al. High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study. Sci Rep. 2022;12(1):16759. https://doi.org/10.1038/s41598-022-21093-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease. Arch Neurol. 1996;53(6):538–42. https://doi.org/10.1001/archneur.1996.00550060082020.

Article  CAS  PubMed  Google Scholar 

Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010;289(1–2):18–22. https://doi.org/10.1016/j.jns.2009.08.034.

Article  PubMed  Google Scholar 

Hanagasi HA, Tufekcioglu Z, Emre M. Dementia in Parkinson’s disease. J Neurol Sci. 2017;374:26–31. https://doi.org/10.1016/j.jns.2017.01.012.

Article  PubMed  Google Scholar 

Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol. 2010;20(3):633–9. https://doi.org/10.1111/j.1750-3639.2009.00369.x.

Article  PubMed  PubMed Central  Google Scholar 

Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387–92. https://doi.org/10.1001/archneur.60.3.387.

Article  PubMed  Google Scholar 

Coughlin DG, Hurtig HI, Irwin DJ. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases. Mov Disord. 2020;35(1):5–19. https://doi.org/10.1002/mds.27867.

Article  PubMed  Google Scholar 

Galvin JE, Balasubramaniam M. Lewy body dementia: the under-recognized but common FOE. Cerebrum. 2013;2013:13.

PubMed  PubMed Central  Google Scholar 

McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89(1):88–100. https://doi.org/10.1212/WNL.0000000000004058.

Article  PubMed  PubMed Central  Google Scholar 

Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34(6):561–6.

Article  PubMed  Google Scholar 

Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386(10004):1683–97. https://doi.org/10.1016/S0140-6736(15)00462-6.

Article  PubMed  PubMed Central  Google Scholar 

Kane JPM, et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018;10(1):19. https://doi.org/10.1186/s13195-018-0350-6.

Article  PubMed  PubMed Central  Google Scholar 

Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013;70(11):1396–402. https://doi.org/10.1001/jamaneurol.2013.3579.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, et al. The costs of dementia subtypes to California Medicare fee-for-service, 2015. Alzheimers Dement. 2019;15(7):899–906. https://doi.org/10.1016/j.jalz.2019.03.015.

Article  PubMed  PubMed Central  Google Scholar 

Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimers Dement. 2017;13(1):28–37. https://doi.org/10.1016/j.jalz.2016.04.002.

Article  PubMed  Google Scholar 

Desai U, et al. Epidemiology and economic burden of Lewy body dementia in the United States. Curr Med Res Opin. 2022;38(7):1177–88. https://doi.org/10.1080/03007995.2022.2059978.

Article  PubMed  Google Scholar 

Hunter CA, Kirson NY, Desai U, Cummings AK, Faries DE, Birnbaum HG. Medical costs of Alzheimer’s disease misdiagnosis among US Medicare beneficiaries. Alzheimers Dement. 2015;11(8):887–95. https://doi.org/10.1016/j.jalz.2015.06.1889.

Article  PubMed  Google Scholar 

Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27(6):954–63. https://doi.org/10.1038/s41591-021-01382-x.

Article  CAS  PubMed  Google Scholar 

Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers. 2015;1:15056. https://doi.org/10.1038/nrdp.2015.56.

Article  PubMed  Google Scholar 

Smedinga M, Darweesh SKL, Bloem BR, Post B, Richard E. Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field. J Neurol. 2021;268(2):724–33. https://doi.org/10.1007/s00415-020-10162-5.

Article  PubMed  Google Scholar 

Sheeler C, Rosa JG, Ferro A, McAdams B, Borgenheimer E, Cvetanovic M. Glia in neurodegeneration: the housekeeper, the defender and the perpetrator. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21239188.

Article  PubMed  PubMed Central  Google Scholar 

Cova I, Priori A. Diagnostic biomarkers for Parkinson’s disease at a glance: where are we? J Neural Transm (Vienna). 2018;125(10):1417–32. https://doi.org/10.1007/s00702-018-1910-4.

Article  CAS  PubMed  Google Scholar 

He R, Yan X, Guo J, Xu Q, Tang B, Sun Q. Recent advances in biomarkers for Parkinson’s disease. Front Aging Neurosci. 2018;10:305. https://doi.org/10.3389/fnagi.2018.00305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chin KS, Teodorczuk A, Watson R. Dementia with Lewy bodies: challenges in the diagnosis and management. Aust N Z J Psychiatry. 2019;53(4):291–303. https://doi.org/10.1177/0004867419835029.

Article  PubMed  Google Scholar 

Pagano G, Niccolini F, Politis M. Imaging in Parkinson’s disease. Clin Med Lond. 2016;16(4):371–5. https://doi.org/10.7861/clinmedicine.16-4-371.

Article  PubMed  PubMed Central  Google Scholar 

MedlinePlus Trusted Health Information for You. https://medlineplus.gov/ency/imagepages/19515.htm. Accessed 5 Sept 2023.

Kaneko Y, et al. Association between clinical symptoms and post-mortem neuropathology in dementia with Lewy bodies. Geriatr Gerontol Int. 2020;20(3):261–2. https://doi.org/10.1111/ggi.13853.

Article  PubMed  PubMed Central  Google Scholar 

Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson’s disease. Brain. 2001;124(Pt 11):2131–46. https://doi.org/10.1093/brain/124.11.2131.

Article  CAS  PubMed  Google Scholar 

Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76. https://doi.org/10.1136/jnnp.2007.131045.

Article  CAS  PubMed  Google Scholar 

Palakurthi B, Burugupally SP. Postural instability in Parkinson’s disease: a review. Brain Sci. 2019. https://doi.org/10.3390/brainsci9090239.

Article  PubMed  PubMed Central  Google Scholar 

Greenland JC, Barker RA. The differential diagnosis of Parkinson’s disease. In: Stoker TB, Greenland JC, editors. Parkinson’s disease: pathogenesis and clinical aspects. Brisbane: Exon Publications; 2018. p. 2018.

Google Scholar 

Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. https://doi.org/10.1016/S0140-6736(14)61393-3.